Skip to content

Study of efficacy and safety of minocycline in pleurodesis

Study of efficacy and safety of minocycline in pleurodesis for postoperative pulmonary fistula

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs061210024
Enrollment
19
Registered
2021-07-15
Start date
2021-12-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pulmonary fistula air leakage

Interventions

Intrapleural administration of minocycline (300 mg) with 1% xylocaine 10 mL and 200 mL saline via chest tube Second administration of minocycline if pulmonary fistula persists 3 days after the first a

Sponsors

Toyooka Shinichi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Cases with postoperative pulmonary fistula at the postoperative day 3 2) The drainage from the chest tube are not bloody, purulent or chylous, and the volume of the drainage for 24 hours is 300 mL or less 3) Age of 20 years or older 4) Signed informed consent

Exclusion criteria

Exclusion criteria: 1) Allergy against minocycline 2) Other patients who are unfit for the study as determined by the attending physician

Design outcomes

Primary

MeasureTime frame
Frequency of removal of the chest tube after the protocol treatment (intrapleural administration of minocycline, up to twice) If the recurrence of pulmonary fistula is observed within 1 week after the removal of the chest tube, such cases are omitted

Secondary

MeasureTime frame
1) Frequency of adverse events 2) Time period until the recurrence of pulmonary fistula

Contacts

Public ContactKen Suzawa

Okayma University Hospital

ksuzawa@okayama-u.ac.jp+81-86-235-7265

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026